History of InCROM Group

InCROM Group consisting of CRO, SMO and site network services started our full-scale clinical trial support services in 1983. Founded in 1975 as RABITON Farm and later incorporated as RABITON Institute, Inc., we evolved from rabbit farming to non-clinical research supporting the conduct of non-clinical studies such as reproductive toxicity studies, and ocular mucosa and skin irritation studies in rabbits. In 1983, we also supported the establishment of Osaka Pharmacology Research Clinic, a facility specialized in clinical trials. As part of the InCROM Group affiliated clinical trial site network, together with Heishinkai Medical Corporation and other core affiliates, and InCROM SMO, InCROM CRO (incorporated in 2010) provides clinical trial support services across a wide array of indications.

InCROM CRO

Being part of the InCROM Group, InCROM CRO leverages on the group resources and collaborations with InCROM (SMO) and affiliate Heishinkai Medical Corporation (Heishinkai) to offer our clients synergies leading to clinical conduct efficiency enhancement. Both InCROM (SMO) and Heishinkai have a wealth of experience and knowledge in clinical pharmacology, allowing us to provide high quality CRO services on tasks such as clinical trial planning consultation, protocol development, clinical trial schedule management, monitoring, data management, statistical analysis, CSR, and GCP audits.

An equally valuable differentiator is our being a smaller organization managed by a strong team of industry and InCROM experienced experts, which enables us to offer clients with a high level of flexibility and responsiveness to any urgent and/or irregular scheduling or other needs. We also contract with partners to offer clinical trial services and solutions, as well as offer on-demand and/or functional service solutions.

Key Strengths

• Extensive experience in clinical pharmacology
• High level of flexibility and responsiveness
• Service speed and quality

InCROM Group Experience

Below is a list of InCROM supported clinical trials (majority conducted at Heishinkai Medical Corporation sites)

(As of June 1, 2022)

Month/Year Study Type Site (Heishinkai site*) CRO Work Scope*
Jun 2021 Phase I OPHAC Hospital* MO, DM, ST, MW, Audit
Apr 2021 Phase I / Ⅱ OPHAC Hospital*
OCROM Clinic*
MO,audit
Apr 2021 BE OPHAC Hospital* MO
Feb 2021 Phase I OPHAC Hospital* MO
Nov 2020 Phase Ⅱ OCROM Clinic* MO, Audit
Nov 2019 Phase I OPHAC Hospital* MO, Audit
Oct 2019 Phase I OPHAC Hospital* MO, DM, ST, MW, Audit
Oct 2019 Phase I OPHAC Hospital* MO, DM, ST, MW, Audit
Sep 2019 Phase I OPHAC Hospital* MO, DM, ST, MW
Jun 2019 Phase Ⅲ Other medical institutions MO, DM, ST, MW, Audit
Jun 2019 BE OPHAC Hospital* MO
Apr 2019 Phase I OPHAC Hospital* MO, DM, ST, MW, Audit
Jan 2019 Phase I OPHAC Hospital* MO
Dec 2018 Phase I OPHAC Hospital* MO, DM, ST, MW
Oct 2018 BE OPHAC Hospital* MO
Oct 2018 Phase I OPHAC Hospital* MO, DM, ST, MW, Audit
Aug 2018 BE OPHAC Hospital* MO
Jul 2018 BE OPHAC Hospital* MO, DM, ST, MW
Mar 2018 Phase Ⅲ OPHAC Hospital*
OCROM Clinic*
ToCROM Clinic*
Other medical institutions
MO, DM, ST, MW, Audit
Jan 2018 Phase I OPHAC Hospital* MO
Oct 2017 Clinical research OPHAC Hospital* MO, DM, ST, MW
Sep 2017 Clinical research OPHAC Hospital*
ToCROM Clinic*
MO, DM, ST, MW, Audit
Aug 2017 Clinical research OPHAC Hospital* MO, DM, ST, MW
Aug 2017 Phase Ⅱ OPHAC Hospital*
ToCROM Clinic*
MO, DM, ST, MW, Audit
Jul 2017 Clinical research OPHAC Hospital* MO, DM, ST, MW
Jul 2017 BE OPHAC Hospital* MO, DM, ST, MW, Audit
Apr 2017 Phase Ⅱ OPHAC Hospital*
Other medical institutions
MO
Mar 2017 Clinical research Other medical institutions MO, DM, MW
Jan 2017 BE OPHAC Hospital* MO, DM, ST, MW
Dec 2016 Clinical research Other medical institutions MO, MW
Dec 2016 Clinical research OPHAC Hospital* MO, DM, ST, MW
Nov 2016 Phase Ⅲ OPHAC Hospital*
ToCROM Clinic*
MO, DM, ST, MW
Sep 2016 BE OPHAC Hospital* MO, DM, MW
Sep 2016 BE OPHAC Hospital* MO, DM, ST, MW
Aug 2016 Clinical Research OPHAC Hospital* MO, DM, ST, MW
Aug 2016 Clinical research OPHAC Hospital* MO, DM, ST, MW
Aug 2016 Clinical research Other medical institutions MO
Feb 2016 Phase I OPHAC Hospital*
ToCROM Clinic*
MO, DM, ST, MW

*MO: monitoring, DM: data management, ST: statistical analysis, MW: medical writing